Loading...
Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint
BACKGROUND: Cardiac magnetic resonance (CMR) can quantify myocardial infarct (MI) size and myocardium at risk (MaR), enabling assessment of myocardial salvage index (MSI). We assessed how MSI impacts the number of patients needed to reach statistical power in relation to MI size alone and levels of...
Saved in:
| Published in: | J Am Heart Assoc |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4943247/ https://ncbi.nlm.nih.gov/pubmed/26961520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.115.002708 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|